2017
DOI: 10.1038/ja.2017.97
|View full text |Cite
|
Sign up to set email alerts
|

Novel approaches for identification of anti-tumor drugs and new bioactive compounds

Abstract: Thanks to the pioneering work done by Professor Hamao Umezawa, bioactive compounds have been used in treatment of several diseases including cancer. In this review, we discuss our work, which focuses on developing new candidates for anti-tumor drugs by screening for bioactive natural compounds in microbial cultures using unique experimental systems. We summarize our recent progress including the following: (1) small-molecule modulators of tumor-stromal cell interactions, (2) inhibitors of three-dimensional sph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 27 publications
1
11
0
Order By: Relevance
“…Despite extensive efforts to develop highly efficient chemotherapeutic molecules, the vast majority of candidate drugs, including several classes of HSP90 inhibitors, have, so far, failed approval by the U.S. Food and Drug Administration ( 56 ). Based on our earlier and present studies, we reason that variability in results could have resulted from drug administration at inconsistent phases of either the tumor or host circadian rhythms ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…Despite extensive efforts to develop highly efficient chemotherapeutic molecules, the vast majority of candidate drugs, including several classes of HSP90 inhibitors, have, so far, failed approval by the U.S. Food and Drug Administration ( 56 ). Based on our earlier and present studies, we reason that variability in results could have resulted from drug administration at inconsistent phases of either the tumor or host circadian rhythms ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…16 Since the toxicity of and tolerance to conventional antitumor drugs greatly limit the treatment outcomes of HCC, natural bioactive substances have become a substitute with great therapeutic potential. 7 Until now, obvious antitumor effects in HCC have been identified in diverse natural bioactive substances, such as gambogic acid, tea catechins, genistein, berberine, resveratrol, curcumin, artemisinin, and matrine. 17 In this study, the antitumor roles of laminarin, a polysaccharide in seaweed, were evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the adverse effects of and drug resistance to conventional antitumor drugs, natural bioactive substances emerge as potential sources of antitumor drugs with low toxicity. 7 Laminarin (1-3,1-6-glucan) is a polysaccharide in seaweed (Laminaria japonica) that is composed of 1,3-and 1,6-glycosidic bond-linked b-D-glucopyranose molecules. Laminarin exhibits bioactivities similar to those of b-glucan, such as immune-enhancing, antioxidant, anti-aging, and antitumor properties.…”
Section: Introductionmentioning
confidence: 99%
“…With the continuous advancement of the lifestyle changes, it is necessary to extract new molecules, which can be potentially used for disease prevention and to find new drugs which may be crucial for cancer patient survival. The natural compounds are extracted in part from vegetal [27], microbial [28], and marine species [29] (Figure 1). Each of these can widely be used as a major source of activities against cancer and other diseases such as diabetes [30], cardiovascular diseases [31], liver diseases [32], asthma [33], neurodegenerative diseases [34], osteoporosis [35], anemia [36], bulimia [37], influenza/ pneumonia [38], renal and thyroid disorders [39,40], nephritis [41], periodontal (gum) disease [42], hypertension [43] and skin disorders [44] (Figure 1).…”
Section: Introductionmentioning
confidence: 99%